Lexeo Therapeutics, Inc. (LXEO)

Latest Insider Confidence Score

2026Q1

49.2
Bearish

Company insider confidence (by quarter)

2023Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Enright Patrick G 10% Owner 319,126 Nov 9, 2023
Tammenoms Bakker Juliet 10% Owner 319,126 Nov 9, 2023
Longitude Capital Partners IV, LLC 10% Owner 319,126 Nov 9, 2023
Longitude Venture Partners IV, L.P. 10% Owner 319,126 Nov 9, 2023
Stampacchia Otello 10% Owner 287,213 Nov 9, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 18, 2026 Feb 20, 2026 Otero Jose Manuel COO Sell 26.3 -3,016 -2.35% ✗ $19.3K
Feb 18, 2026 Feb 20, 2026 Townsend Richard Nolan CEO Sell 22.5 -10,173 -2.53% ✗ $64.9K
Nov 18, 2025 Feb 20, 2026 Otero Jose Manuel COO Sell 27.5 -721 -1.12% ✗ $6.7K
Feb 13, 2026 Feb 17, 2026 Bhalla Narinder Pal Chief Medical Officer Neutral 90.0 +49,500 100.00% ✗ -
Feb 4, 2026 Feb 6, 2026 Townsend Richard Nolan CEO Neutral 90.0 +161,665 67.08% ✗ -
Feb 4, 2026 Feb 6, 2026 Otero Jose Manuel COO Neutral 90.0 +65,000 102.40% ✗ -
Feb 4, 2026 Feb 6, 2026 Tamayo Louis Edward CFO Neutral 90.0 +44,665 99.26% ✗ -
Feb 5, 2026 Bhalla Narinder Pal Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 18, 2025 Nov 20, 2025 Townsend Richard Nolan CEO Sell 43.8 -1,127 -0.47% ✗ $10.4K
Nov 18, 2025 Nov 20, 2025 Adler Eric Chief Medical Officer Sell 37.5 -615 -0.84% ✗ $5.7K
Nov 18, 2025 Nov 20, 2025 See Tai Sandi Chief Development Officer Sell 37.5 -386 -0.59% ✗ $3.6K
Nov 18, 2025 Nov 20, 2025 Robertson Jenny Chief Legal Officer Sell 37.5 -549 -0.80% ✗ $5.1K
Aug 18, 2025 Nov 20, 2025 Otero Jose Manuel Chief Technical Officer Sell 27.5 -721 -1.12% ✗ $6.7K
Oct 15, 2025 Oct 17, 2025 See Tai Sandi Chief Development Officer Sell 91.3 +7,002 11.90% ✗ $34.8K
Oct 15, 2025 Oct 17, 2025 Robertson Jenny Chief Legal Officer Sell 91.3 +6,374 10.19% ✗ $31.5K
Oct 15, 2025 Oct 17, 2025 Otero Jose Manuel Chief Technical Officer Sell 86.3 +3,825 6.34% ✗ $18.9K
Oct 15, 2025 Oct 17, 2025 Adler Eric Chief Medical Officer Sell 86.3 +6,188 9.23% ✗ $30.2K
Oct 15, 2025 Oct 17, 2025 Townsend Richard Nolan CEO Sell 90.0 +19,867 8.94% ✗ $117.4K
Sep 12, 2025 Sep 16, 2025 Townsend Richard Nolan CEO Neutral 67.5 +2,193 1.00% ✗ -
Aug 18, 2025 Sep 10, 2025 Townsend Richard Nolan CEO Sell 37.5 -1,115 -0.50% ✗ $5.2K
Aug 29, 2025 Sep 3, 2025 Tamayo Louis Edward CFO Neutral 90.0 +45,000 100.00% ✗ -
Aug 27, 2025 Tamayo Louis Edward CFO Neutral 52.5 - 0.00% ✗ -
Aug 18, 2025 Aug 20, 2025 Otero Jose Manuel Chief Technical Officer Sell 26.3 -2,848 -4.50% ✗ $13.3K
Aug 18, 2025 Aug 20, 2025 Robertson Jenny Chief Legal Officer Sell 37.5 -542 -0.86% ✗ $2.5K
Aug 18, 2025 Aug 20, 2025 Adler Eric Chief Medical Officer Sell 37.5 -608 -0.90% ✗ $2.8K
Aug 18, 2025 Aug 20, 2025 Townsend Richard Nolan CEO Sell 26.3 -2,735 -1.23% ✗ $12.8K
Aug 18, 2025 Aug 20, 2025 See Tai Sandi Chief Development Officer Sell 37.5 -382 -0.64% ✗ $1.8K
Jun 26, 2025 Jun 30, 2025 Tanguler Tolga Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 Van Hauwermeiren Timothy Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 DIAZ REINALDO M Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 COOPERSTONE BRENDA Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 CHOLMONDELEY PAULA H Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 Altschuler Steven Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2025 Jun 30, 2025 Agger Mette Kirstine Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 20, 2025 Townsend Richard Nolan CEO Sell 45.0 -1,074 -0.48% ✗ $3K
May 16, 2025 May 20, 2025 Adler Eric Chief Medical Officer Sell 37.5 -585 -0.86% ✗ $1.6K
May 16, 2025 May 20, 2025 Robertson Jenny Chief Legal Officer Sell 37.5 -521 -0.82% ✗ $1.4K
May 16, 2025 May 20, 2025 See Tai Sandi Chief Development Officer Sell 37.5 -367 -0.62% ✗ $1K
Mar 14, 2025 Apr 9, 2025 Otero Jose Manuel Chief Technical Officer Neutral 85.0 +5,720 9.95% ✗ -
Mar 14, 2025 Apr 9, 2025 Robertson Jenny Chief Legal Officer Neutral 85.0 +5,720 9.88% ✗ -
Mar 14, 2025 Apr 9, 2025 See Tai Sandi Chief Development Officer Neutral 90.0 +5,720 10.61% ✗ -
Mar 14, 2025 Apr 1, 2025 Townsend Richard Nolan CEO Neutral 67.5 +2,128 0.97% ✗ -
Feb 19, 2025 Feb 21, 2025 Townsend Richard Nolan CEO Sell 26.3 -4,326 -1.93% ✗ $19.1K
Feb 19, 2025 Feb 21, 2025 See Tai Sandi Chief Development Officer Sell 27.5 -1,486 -2.68% ✗ $6.6K
Feb 19, 2025 Feb 21, 2025 Adler Eric Chief Medical Officer Sell 26.3 -2,359 -3.34% ✗ $10.4K
Feb 19, 2025 Feb 21, 2025 Robertson Jenny Chief Legal Officer Sell 27.5 -2,101 -3.50% ✗ $9.3K
Jan 17, 2025 Jan 22, 2025 Rasbach Kyle CFO Neutral 90.0 +40,875 100.00% ✗ -
Jan 7, 2025 Jan 10, 2025 Townsend Richard Nolan CEO Neutral 90.0 +103,750 85.96% ✗ -
Jan 7, 2025 Jan 10, 2025 Otero Jose Manuel Chief Technical Officer Neutral 90.0 +26,250 84.00% ✗ -
Jan 7, 2025 Jan 10, 2025 Robertson Jenny Chief Legal & Admin Officer Neutral 90.0 +36,250 152.63% ✗ -
Jan 7, 2025 Jan 10, 2025 See Tai Sandi Chief Development Officer Neutral 90.0 +38,750 233.08% ✗ -
Jan 7, 2025 Jan 10, 2025 Adler Eric Chief Medical Officer Neutral 90.0 +43,750 162.79% ✗ -
Dec 27, 2024 Rasbach Kyle CFO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2024 Dec 12, 2024 Townsend Richard Nolan CEO Sell 45.0 -2,500 -2.03% ✓ $20.5K
Nov 25, 2024 Nov 26, 2024 CHOLMONDELEY PAULA H Director Buy 95.0 +15,000 95.99% ✗ $104.9K
Nov 11, 2024 Nov 13, 2024 Tanguler Tolga Director Neutral 52.5 - 0.00% ✗ -
Nov 11, 2024 Nov 13, 2024 Townsend Richard Nolan CEO Sell 45.0 -2,500 -2.03% ✓ $19.6K
Nov 13, 2024 Tanguler Tolga Director Neutral 52.5 - 0.00% ✗ -
Oct 10, 2024 Oct 15, 2024 Townsend Richard Nolan CEO Sell 41.3 -5,000 -3.98% ✓ $40.5K
Sep 10, 2024 Sep 11, 2024 Townsend Richard Nolan CEO Sell 37.5 -5,000 -3.98% ✓ $53.3K
Aug 12, 2024 Aug 13, 2024 Townsend Richard Nolan CEO Sell 37.5 -5,000 -3.98% ✓ $57.6K
Jul 10, 2024 Jul 12, 2024 Townsend Richard Nolan CEO Sell 7.5 -55,000 -31.30% ✓ $923.4K
Jul 5, 2024 Jul 8, 2024 Van Hauwermeiren Timothy Director Neutral 52.5 - 0.00% ✗ -
Jul 8, 2024 Van Hauwermeiren Timothy Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Jun 27, 2024 COOPERSTONE BRENDA Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Jun 27, 2024 Altschuler Steven Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Jun 27, 2024 DIAZ REINALDO M Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Jun 27, 2024 CHOLMONDELEY PAULA H Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2024 Jun 27, 2024 Agger Mette Kirstine Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 14, 2024 Otero Jose Manuel Chief Technical Officer Neutral 90.0 +31,250 100.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Townsend Richard Nolan CEO Sell 41.3 -5,000 -2.85% ✓ $88.3K
May 22, 2024 Otero Jose Manuel Chief Technical Officer Neutral 52.5 - 0.00% ✗ -
May 13, 2024 May 14, 2024 Townsend Richard Nolan CEO Sell 41.3 -5,000 -2.85% ✓ $66.1K
Feb 6, 2024 See Tai Sandi Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 DIAZ REINALDO M Director Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 Agger Mette Kirstine Director Neutral 52.5 - 0.00% ✗ -
Feb 2, 2024 Feb 6, 2024 Adler Eric Chief Medical Officer Neutral 90.0 +26,875 100.00% ✗ -
Jan 5, 2024 Jan 9, 2024 Townsend Richard Nolan CEO Neutral 90.0 +43,750 34.46% ✗ -
Jan 5, 2024 Jan 9, 2024 Robertson Jenny Chief Legal and Admin Officer Neutral 90.0 +23,750 100.00% ✗ -
Nov 7, 2023 Nov 9, 2023 Omega Fund VI, L.P. 10% Owner Buy 100.0 +454,545 26.69% ✗ $5M
Nov 7, 2023 Nov 9, 2023 McCormac Paul Chief Technical Officer Neutral 52.5 - 0.00% ✗ -
Nov 7, 2023 Nov 9, 2023 Lundbeckfond Invest A/S 10% Owner Buy 100.0 +227,272 14.13% ✗ $2.5M
Nov 7, 2023 Nov 9, 2023 Longitude Capital Partners IV, LLC 10% Owner Buy 100.0 +454,545 21.52% ✗ $5M
Nov 2, 2023 Townsend Richard Nolan CEO Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Robertson Jenny Chief Legal and Admin. Officer Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Omega Fund VI, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 McCormac Paul Chief Technical Officer Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Lundbeckfond Invest A/S 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Longitude Capital Partners IV, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 DIAZ REINALDO M Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Davitian Bernard Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 COOPERSTONE BRENDA Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 CHOLMONDELEY PAULA H Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Altschuler Steven Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Agger Mette Kirstine Director Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Adler Eric Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -